Literature DB >> 20521050

Stenting of the upper gastrointestinal tract: current status.

Konstantinos Katsanos1, Tarun Sabharwal, Andreas Adam.   

Abstract

Minimally invasive image-guided insertion of self-expanding metal stents in the upper gastrointestinal tract is the current treatment of choice for palliation of malignant esophageal or gastroduodenal outlet obstructions. A concise review is presented of contemporary stenting practice of the upper gastrointestinal tract, and the procedures in terms of appropriate patient evaluation, indications, and contraindications for treatment are analyzed, along with available stent designs, procedural steps, clinical outcomes, inadvertent complications, and future technology. Latest developments include biodegradable polymeric stents for benign disease and radioactive or drug-eluting stents for malignant obstructions.

Entities:  

Mesh:

Year:  2010        PMID: 20521050     DOI: 10.1007/s00270-010-9862-6

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  16 in total

1.  The clinical research of the endoscopic sequential treatment for patients with intermediate-advanced esophageal cancer: a randomized clinical trial.

Authors:  Liming Wen; Honglin Quan; Linyan Li; Chun Huang; Xiaohui Chen; Yaling Yang; Liming Wang; Xiguo He; Xudong Zhang
Journal:  Med Oncol       Date:  2014-11-08       Impact factor: 3.064

2.  An unusual complication of esophageal stenting for corrosive Acid injury.

Authors:  Kirti Katherine Kabeer; N Ananthakrishnan; S Manoj Karthik; R Pajanivel; M Ravishankar
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  SEMS vs cSEMS in duodenal and small bowel obstruction: high risk of migration in the covered stent group.

Authors:  Oliver Waidmann; Jörg Trojan; Mireen Friedrich-Rust; Christoph Sarrazin; Wolf Otto Bechstein; Frank Ulrich; Stefan Zeuzem; Jörg Gerhard Albert
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

4.  Surgery Complicated by Self-Expandable Metallic Stents (SEMS) Tracheal Stent in a Congenital H-type Tracheo-Esophageal Fistula.

Authors:  Murugappan Nachiappan; Ravikiran Thota; Srikanth Gadiyaram
Journal:  Cureus       Date:  2022-02-10

5.  Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer.

Authors:  Sang Myung Woo; Dong Hwan Kim; Woo Jin Lee; Kyung Woo Park; Sang-Jae Park; Sung-Sik Han; Tae Hyun Kim; Young Hwan Koh; Hyun Bum Kim; Eun Kyung Hong
Journal:  Surg Endosc       Date:  2013-01-04       Impact factor: 4.584

6.  Carcinomatosis matters: clinical outcomes and prognostic factors for clinical success of stent placement in malignant gastric outlet obstruction.

Authors:  Han Ho Jeon; Chan Hyuk Park; Jun Chul Park; Choong Nam Shim; Sunyong Kim; Hyun Jik Lee; Hyuk Lee; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Surg Endosc       Date:  2013-11-02       Impact factor: 4.584

7.  Development of an endoluminal intestinal attachment for a clinically applicable distraction enterogenesis device.

Authors:  Farokh R Demehri; Brent Utter; Jennifer J Freeman; Yumi Fukatsu; Jonathan Luntz; Diann Brei; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2015-10-22       Impact factor: 2.545

8.  Improvement of quality of life and survival using self-expandable metal stent placement for severe malignant stenosis of the gastric body: a case report.

Authors:  Hozumi Kumagai; Kenta Nio; Tsuyoshi Shirakawa; Keita Uchino; Hitoshi Kusaba; Taichi Isobe; Masato Komoda; Shingo Tamura; Ryo Maeyama; Eishi Nagai; Koichi Akashi; Eishi Baba
Journal:  J Med Case Rep       Date:  2012-09-19

9.  Esophageal stenting in the setting of malignancy.

Authors:  Juan Carlos Martinez; Matthew M Puc; Roderick M Quiros
Journal:  ISRN Gastroenterol       Date:  2011-08-08

10.  Clinical application of iodine-eluting stent in patients with advanced esophageal cancer.

Authors:  Zhenbo Dai; Dejun Zhou; Jianzhang Hu; Lei Zhang; Yunshou Lin; Jing Zhang; Fengling Li; Peng Liu; Hua Li; Fuliang Cao
Journal:  Oncol Lett       Date:  2013-07-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.